Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presatovir (GS-5806) in healthy volunteers infected with RSV
NCT01756482Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2012
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of presatovir in respiratory syncytial virus infection (RSV), sponsored by Gilead Sciences. Started Nov 2012; status: completed.
02
Drugs
presatovir
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT01756482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756482.